UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046568
Receipt number R000052794
Scientific Title Assessment of Clinical Performance of an AI Program for Measuring Thoracic Aortic Diameter
Date of disclosure of the study information 2022/01/11
Last modified on 2023/01/07 12:57:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Assessment of Clinical Performance of an AI Program for Measuring Thoracic Aortic Diameter

Acronym

Assessment of Clinical Performance of an AI Program for Measuring Thoracic Aortic Diameter

Scientific Title

Assessment of Clinical Performance of an AI Program for Measuring Thoracic Aortic Diameter

Scientific Title:Acronym

Assessment of Clinical Performance of an AI Program for Measuring Thoracic Aortic Diameter

Region

Japan


Condition

Condition

Thoracic aortic aneurysm

Classification by specialty

Radiology Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the clinical feasibility of AI-assisted measurement of the aortic diameter.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Comparison of aorta diameters on non-contrast CT images measured by a medical doctor with the assistance of the prototype AI software and those on contrast enhanced CT images assessed by medical doctors (ground truth).

Key secondary outcomes

1. Comparison of aortic diameter measurement solely by a medical doctor or by the AI software using non-contrast CT and ground truth.
2. Comparison of aortic diameter measurements solely by the AI software using contrast enhanced CT and ground truth.
3. Comparison of aortic diameter measurement by maximal short diameter method and ground truth.
4. Influence of the AI software on interobserver variance.
5. Influence of the AI software on the reading time.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

22 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who are scheduled for CT scan to examine aortic disease, especially thoracic aortic aneurysm or to follow-up thoracic aortic aneurysm.

Key exclusion criteria

1) Suboptimal image quality of the thoracic aorta limiting evaluation of the aortic diameter.
2) Under 22 years of age at the time of obtaining consent.
3) With allergy to iodine contrast media.
4) With active asthma.
5) With Grade 4 or higher renal dysfunction (eGFR less than 30 ml/min/1.73m2).
6) Others who are judged by the principal investigator to be unsuitable as subjects.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Nobuo
Middle name
Last name Tomizawa

Organization

Juntendo University Hospital

Division name

Department of Radiology

Zip code

113-8431

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan

TEL

03-3813-3111

Email

n-tomizawa@juntendo.ac.jp


Public contact

Name of contact person

1st name Akiyoshi
Middle name
Last name Suzuki

Organization

Juntendo University Hospital

Division name

Department of Radiology

Zip code

113-8431

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan

TEL

03-3813-3111

Homepage URL


Email

a.suzuki.eh@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Juntendo University School of Medicine

Address

3-1-3 Hongo, Bunkyo-ku, Tokyo, Japan

Tel

03-5802-1584

Email

hongo-rinri@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Juntendo University Hospital (Tokyo)


Other administrative information

Date of disclosure of the study information

2022 Year 01 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 11 Month 12 Day

Date of IRB

2021 Year 11 Month 12 Day

Anticipated trial start date

2021 Year 12 Month 01 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

To observe CT images performed for examination of aortic disease such as aortic aneurysm or for follow-up of aortic aneurysm.


Management information

Registered date

2022 Year 01 Month 06 Day

Last modified on

2023 Year 01 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052794


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name